Market Cap (In USD)
10.35 Million
Revenue (In USD)
1.54 Million
Net Income (In USD)
-16.29 Million
Avg. Volume
6673.00
- Currency
- USD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 0.045-0.22
- PE
- -
- EPS
- -
- Beta Value
- 2.386
- ISIN
- CA71716K1012
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Mr. Marc Lustig M.B.A., M.Sc.
- Employee Count
- -
- Website
- https://www.pharmacielo.com
- Ipo Date
- 2019-01-25
- Details
- PharmaCielo Ltd., together with its subsidiary, cultivates, processes, produces, and supplies medicinal-grade cannabis extracts, tetrahydrocannabinol, and related products. The company also offers telemedicine software. It serves health and wellness product manufacturers, pharmacies, medical clinics, and cosmetic companies in Canada and Colombia. The company has a strategic alliance with AssuredTrans Inc. PharmaCielo Ltd. is headquartered in Toronto, Canada.
More Stocks
-
8620
-
CBSTF
-
BJCHF
-
DOMWFPrime Drink Group Corp.
DOMWF
-
BTURF
-
SBOK
-
GLOBALVECTGlobal Vectra Helicorp Limited
GLOBALVECT
-
NGNENeurogene Inc.
NGNE